AZTAAzenta Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · azenta.com

37.40USD+5.00%Mkt Cap: 1.64B $P/E: —3d ago

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and int…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap1.64B $

Enterprise Value1.33B $

Revenue (TTM)613.81M $

Gross Profit270.28M $

Net Income (TTM)-55.76M $

Revenue/Share13.41 USD

Last Price37.40 USD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees2.9K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)61.88

PEG0.53

EV/EBITDA40.22

EV/Revenue2.16

P/S2.61

P/B1.06

EPS (TTM)-2.52

EPS (Forward)0.59

52W Range

15.9383% of range41.73

52W High41.73 USD

52W Low15.93 USD

Profitability

Gross Margin45.52%

Oper. Margin-2.27%

EBITDA Margin5.38%

Profit Margin-9.39%

ROE-3.23%

ROA-2.71%

Growth

Revenue Growth12.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF72.18M $

CapEx (TTM)33.86M $

FCF Margin10.32%

FCF Yield3.87%

Net Debt-271.83M $

Net Debt/EBITDA-8.24

Balance Sheet

Debt/Equity0.03

Current Ratio2.50

Quick Ratio1.85

Book Value/Sh34.51 USD

Cash/Share7.437 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield0.83%

Payout Ratio0.00%

Ex-Div DateDec 2, 2021

Pay DateDec 23, 2021

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)34.80 USD

Upside (mean)-7.0%

Target Range33.00 USD – 37.00 USD

$33.00-7.0% to mean$37.00

# Analysts5

Ownership

Shares Out.43.81M

Float38.38M

Insiders1.05%

Institutions117.30%

Short Interest

Short Ratio9.1d

Short % Float19.82%

Short % Out.12.20%

Shares Short5.34M

Short (prev mo.)6.22M

Technical

SMA 5027.54 (+35.8%)

SMA 20028.16 (+32.8%)

Beta1.38

S&P 52W Chg18.16%

Avg Vol (30d)632.15K

Avg Vol (10d)632.65K

Technical Indicators

RSI (14)81.1

MACD2.4487

MACD Signal2.0583

MACD Hist.+0.3904

BB Upper37.11 USD

BB Middle31.30 USD

BB Lower25.50 USD

BB Width37.08%

ATR (14)1.385 USD

Vol Ratio (20d)0.96x